Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Taxotere Followed by Myocet and Cyclophosphamide in HER2- Breast Cancer
NCT00721747Phase 2Unknown
- Sponsor
- Grupo Oncológico Gallego
- Start
- Jan 2008
- Primary completion
- Jan 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in breast cancer, sponsored by Grupo Oncológico Gallego. Status: unknown.
02
Drugs
doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00721747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00721747.